Glycerol Phenylbutyrate API is a pharmaceutical-grade nitrogen-binding agent indicated for the long-term management of urea cycle disorders (UCDs) in patients who cannot effectively eliminate ammonia through the normal urea cycle. After oral administration, it is metabolized to phenylbutyrate and subsequently phenylacetate, which binds with glutamine to facilitate the excretion of excess nitrogen through the kidneys.
This mechanism helps reduce elevated blood ammonia levels (hyperammonemia), minimizing the risk of neurological complications associated with urea cycle disorders. Glycerol Phenylbutyrate is commonly used alongside dietary protein restriction and nutritional management as part of a comprehensive treatment plan.
Swapnroop Drugs and Pharmaceuticals manufactures premium-quality Glycerol Phenylbutyrate API under stringent WHO-GMP manufacturing standards. Every batch is tested for purity, assay, stability, and pharmaceutical quality to ensure compliance with international standards. Complete regulatory documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), and technical specifications, is available.
Glycerol Phenylbutyrate API is supplied in pharmaceutical-grade HDPE containers, aluminum containers, or customized packaging suitable for commercial production.
Available Packaging Options:
Each shipment includes:
The CAS Number of Glycerol Phenylbutyrate API is 301-54-8.
It is used for the long-term treatment of urea cycle disorders (UCDs) to help reduce elevated blood ammonia levels.
It is metabolized to phenylacetate, which binds with glutamine to remove excess nitrogen from the body through urinary excretion, helping control hyperammonemia.
Yes. We provide Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), technical specifications, and complete regulatory documentation.
Yes. We supply commercial quantities worldwide with reliable export support and customized packaging.
Get Bulk Quote via WhatsApp